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Abstract
© 2017, Marmara University. All rights reserved. Adequate treatment of Parkinson’s disease is
an important medical issue. Patients are suffered from numerous side effects of the widely used
drugs. It has been found recently that monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)
cyclohex-3-ene-1,2-diol and its diacetate demonstrate high antiparkinsonian activity in some
animal models. At the same time, their genetic safety was not studied yet. The aim of this
research was to investigate the effect of these compounds with antiparkinsonian activities on
reproduction of D. melanogaster. Over 4000 of fruitflies cultivated under the action of these
compounds were analyzed. It was found that the chemicals did not provoke genetic mutations
or alter reproduction of D. melanogaster. The possible explanations for the detected phenomena
are provided. It was found that the compounds do not affect fertility in Drosophila..
http://dx.doi.org/10.12991/mpj.2017.29
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